186 related articles for article (PubMed ID: 23075455)
1. Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.
Matsuno RK; Pagano IS; Maskarinec G; Issell BF; Gotay CC
J Womens Health (Larchmt); 2012 Dec; 21(12):1252-8. PubMed ID: 23075455
[TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in complementary and alternative medicine use among cancer patients.
Maskarinec G; Shumay DM; Kakai H; Gotay CC
J Altern Complement Med; 2000 Dec; 6(6):531-8. PubMed ID: 11152058
[TBL] [Abstract][Full Text] [Related]
3. Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer.
Saquib J; Parker BA; Natarajan L; Madlensky L; Saquib N; Patterson RE; Newman VA; Pierce JP
Complement Ther Med; 2012 Oct; 20(5):283-90. PubMed ID: 22863642
[TBL] [Abstract][Full Text] [Related]
4. Ethnicity and breast cancer in Hawaii: increased survival but continued disparity.
Braun KL; Fong M; Gotay C; Pagano IS; Chong C
Ethn Dis; 2005; 15(3):453-60. PubMed ID: 16108306
[TBL] [Abstract][Full Text] [Related]
5. Perceptions and use of complementary and alternative medicine in American Samoa: a survey of health care providers.
Krosch SL
Hawaii Med J; 2010 Jun; 69(6 Suppl 3):21-6. PubMed ID: 20539997
[TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative therapies among very long-term breast cancer survivors.
Carpenter CL; Ganz PA; Bernstein L
Breast Cancer Res Treat; 2009 Jul; 116(2):387-96. PubMed ID: 18712472
[TBL] [Abstract][Full Text] [Related]
7. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
Wyatt G; Sikorskii A; Wills CE; Su H
Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
[TBL] [Abstract][Full Text] [Related]
8. Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study.
Neuhouser ML; Smith AW; George SM; Gibson JT; Baumgartner KB; Baumgartner R; Duggan C; Bernstein L; McTiernan A; Ballard R
Breast Cancer Res Treat; 2016 Dec; 160(3):539-546. PubMed ID: 27766453
[TBL] [Abstract][Full Text] [Related]
9. Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.
Mohd Mujar NM; Dahlui M; Emran NA; Abdul Hadi I; Wai YY; Arulanantham S; Hooi CC; Mohd Taib NA
PLoS One; 2017; 12(4):e0176394. PubMed ID: 28448541
[TBL] [Abstract][Full Text] [Related]
10. Use of complementary and alternative medicine among breast cancer survivors.
Saibul N; Shariff ZM; Rahmat A; Sulaiman S; Yaw YH
Asian Pac J Cancer Prev; 2012; 13(8):4081-6. PubMed ID: 23098520
[TBL] [Abstract][Full Text] [Related]
11. The high and heterogeneous burden of breast cancer in Hawaii: A unique multiethnic U.S. Population.
Loo LWM; Williams M; Hernandez BY
Cancer Epidemiol; 2019 Feb; 58():71-76. PubMed ID: 30503975
[TBL] [Abstract][Full Text] [Related]
12. Surviving breast cancer: the role of complementary therapies.
Canales MK; Geller BM
Fam Community Health; 2003; 26(1):11-24. PubMed ID: 12802124
[TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer.
Mueller CM; Mai PL; Bucher J; Peters JA; Loud JT; Greene MH
BMC Complement Altern Med; 2008 Apr; 8():17. PubMed ID: 18447953
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.
Kawai M; Tomotaki A; Miyata H; Iwamoto T; Niikura N; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Nakamura S; Tokuda Y
Cancer Med; 2016 Jun; 5(6):1328-40. PubMed ID: 26923549
[TBL] [Abstract][Full Text] [Related]
15. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry.
Zhang FF; Haslam DE; Terry MB; Knight JA; Andrulis IL; Daly MB; Buys SS; John EM
Cancer; 2017 Jun; 123(11):2070-2079. PubMed ID: 28263368
[TBL] [Abstract][Full Text] [Related]
16. Symptom severity, symptom interference and use of complementary and alternative medicine among survivors of colorectal and breast cancer after curative treatment in Taiwan.
Wu HJ; Tai CJ; Tai CJ; Chien LY
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12925. PubMed ID: 30276957
[TBL] [Abstract][Full Text] [Related]
17. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005.
Boon HS; Olatunde F; Zick SM
BMC Womens Health; 2007 Mar; 7():4. PubMed ID: 17397542
[TBL] [Abstract][Full Text] [Related]
18. Classification of CAM use and its correlates in patients with early-stage breast cancer.
Saquib J; Madlensky L; Kealey S; Saquib N; Natarajan L; Newman VA; Patterson RE; Pierce JP
Integr Cancer Ther; 2011 Jun; 10(2):138-47. PubMed ID: 21382963
[TBL] [Abstract][Full Text] [Related]
19. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors.
Wernli KJ; Hampton JM; Trentham-Dietz A; Newcomb PA
Pharmacoepidemiol Drug Saf; 2011 Feb; 20(2):131-7. PubMed ID: 21254283
[TBL] [Abstract][Full Text] [Related]
20. Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey.
Nagel G; Hoyer H; Katenkamp D
Support Care Cancer; 2004 Nov; 12(11):789-96. PubMed ID: 15338384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
